Clinical Trials on Malabsorption in Netherlands

Total 18 results

Maastricht University Medical Center
FrieslandCampina

Completed

The Incorporation of Dietary Protein-Derived Amino Acids in Duodenal Epithelium (GutFeeding)

Protein Malabsorption

Netherlands
Maastricht University Medical Center
Maastricht University

Completed

Protein-bound Versus Free Amino Acid Nutrition During INtestinal Malabsorption in Critical Illness (PANINI)

Critical Illness | Protein Malnutrition | Intestinal Malabsorption

Netherlands
Amsterdam UMC, location VUmc
Leiden University Medical Center; DSM Food Specialties

Completed

Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease

Celiac Disease

Netherlands
Nestlé

Completed

Probiotic BL NCC 2705 and Gluten Sensitivity

Celiac Disease | Non-celiac Gluten Sensitivity

Netherlands
Leiden University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Enrolling by invitation

"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease" (GLUTEN-GEN)

Celiac Disease in Children

Netherlands
Topas Therapeutics GmbH

Recruiting

A Study to Assess the Safety of TPM502 in Adults With Celiac Disease

Celiac Disease

Australia, Norway, Finland, Netherlands, Sweden, Germany
Radboud University Medical Center

Completed

Does B Vitamin Supplementation Decrease Homocysteine Concentrations in Newborns

Mild Hyperhomocysteinemia

Netherlands
Nutrinia

Unknown

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Premature Birth of Newborn | Intestinal Malabsorption

Spain, United States, Netherlands, Belgium, United Kingdom, Israel, Italy, Hungary, France, Germany
Medisch Spectrum Twente
Medical School Medisch Spectrum Twente; Techmed University of Twente; Erasmus...

Recruiting

Coeliac Artery Release or Sham Operation (CARoSO)

Mesenteric Ischemia | Median Arcuate Ligament Syndrome | Dunbar Syndrome | Coeliac Artery Compression | Celiac Artery Compression Syndrome

Netherlands
Provention Bio, a Sanofi Company

Active, not recruiting

PRV-015 in Gluten-free Diet Non-responsive Celiac Disease (PROACTIVE)

Celiac Disease

United States, Canada, Netherlands, Spain
Zealand Pharma

Enrolling by invitation

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial (EASE SBS 3)

Short Bowel Syndrome

Germany, United States, Belgium, Denmark, France, United Kingdom, Netherlands, Poland
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Short Bowel Syndrome

United States, Denmark, France, Canada, Belgium, Netherlands, Poland, United Kingdom
Calypso Biotech BV

Completed

Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis

Celiac Disease | Eosinophilic Esophagitis

Netherlands, Belgium, Finland, Germany, Norway
Zealand Pharma

Completed

Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) (EASE SBS 1)

Short Bowel Syndrome

United States, Denmark, Belgium, Germany, France, United Kingdom, Canada, Netherlands, Poland
Zealand Pharma

Recruiting

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS (EASE SBS 2)

Short Bowel Syndrome

United States, France, Belgium, Denmark, United Kingdom, Germany, Canada, Italy, Netherlands, Poland
Shire

Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

Short Bowel Syndrome

United States, France, Germany, Canada, Netherlands, Poland, Denmark, Belgium, United Kingdom
Shire
Nycomed

Completed

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects (STEPS)

Short Bowel Syndrome

United States, Spain, France, Canada, Netherlands, Denmark, Germany, Italy, Poland, United Kingdom
Amgen

Completed

Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease

Type II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell Lymphoma

Spain, United States, Finland, France, Netherlands

Clinical Trials on Malabsorption in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations